Polio Research Today is a free monthly online journal that collates and summarizes the latest research about Polio, including details on symptoms, treatment, vaccines, causes, virus.

Policy. OPV cessation--the final step to a "polio-free" world.

Aylward RB, Sutter RW, Heymann DL

Global Polio Eradication Initiative, World Health Organization, Geneva 27 Switzerland. aylwardb@who.int

The 20-year, U.S. $4 billion-dollar international effort to eradicate wild polioviruses now includes monovalent oral poliovirus type 1 vaccine (mOPV1), which was first given to 40 million children in India in April 2005. As this vaccine is being introduced to eliminate some of the last poliovirus reservoirs, the Global Polio Eradication Initiative is planning for the eventual synchronized worldwide cessation of the routine use of all oral poliovirus vaccines (OPVs) because of their capacity to cause, rarely, outbreaks of paralytic poliomyelitis. This Policy Forum reviews the feasibility and implications of eventually stopping the use of live polio vaccines.

Published 28 October 2005 in Science, 310(5748): 625-6.
Full-text of this article is available online (may require subscription).

© 2004-2008 Polio Research Today. All Rights Reserved.